The hidden cost of racism in sickle cell disease treatment
Sickle cell disease (SCD) is frequently referred to as an invisible disease and is often overlooked due to a lack of research and overall resource shortages resulting in substandard clinical care. Part of the problem is difficulty objectively identifying SCD characteristics due to lack of laboratory markers and poor objective pain indicators. This disease mainly affects African American populations. Systemic marginalization of stigmatized populations results in less funding; and therefore, …
